Mark Sonderup is the incumbent Head of the Division of Hepatology, Liver and Liver Transplant Clinic at the University of Cape Town and Groote Schuur Hospital, Cape Town, South Africa

I am studying mechanisms of cell death escape by liver cancer cells as a consequence of oncogenic mutations and/or metabolic reprogramming. I obtained a Bachelor of Science in Molecular Biology, a Master of Science in Biomedical Sciences and a PhD in Experimental Oncology from University of Torino, Italy. After training as a visiting graduate student first and postdoctoral research fellow at the Cleveland Clinic and University of California San Diego, I joined Jecure Therapeutics as a research scientist for three years.

Dr. Tincopa completed her medical degree and residency in internal medicine at Johns Hopkins University. She completed gastroenterology and transplant hepatology fellowship at the University of Michigan. Dr. Tincopa has a Masters degree in Health and Healthcare Research from the University of Michigan and is also board certified in Obesity Medicine.

Dr. Veeral Ajmera is Associate Professor of Medicine in the Division of Gastroenterology and Hepatology and Medical Director of Liver Transplantation at the University of California, San Diego. Dr. Ajmera serves as an investigator in the UCSD Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD) Research Unit where his research focuses on non-invasive biomarkers, genetics and patient factors associated with disease severity and prognosis.

Matthew Kappus, MD is the medical director for the living donation liver transplant and combined heart-liver transplant programs at Duke University Hospital. He conducts research in understanding physical function and transplant optimization for those undergoing liver transplantation.

Doug Simonetto is a Transplant Hepatology and Associate Professor of Medicine at Mayo Clinic, Rochester. He serves as the Director of the Gastroenterology and Hepatology Fellowship Program and Co-Director of Data Analytics and Artificial Intelligence Laboratory. His research focuses on portal hypertension and alcohol-associated liver disease.

Karn Wijarnpreecha, M.D., M.P.H., is a Transplant Hepatologist at Mayo Clinic in Jacksonville, Florida. He previously served as Associate Professor of Medicine and Director of Clinical Research in the Division of Gastroenterology and Hepatology at the University of Arizona College of Medicine–Phoenix and Banner University Medical Center Phoenix. He is board-certified in internal medicine, gastroenterology, transplant hepatology, and obesity medicine.

.

I am an Associate Professor of Medicine at Virginia Commonwealth University and serve as faculty for the Stravitz-Sanyal Institute for Liver Disease and Metabolic Health. My areas of interest are clinical trials, biomarker development and steatohepatitis from both alcohol and the Metabolic syndrome.

Rena K. Fox, MD, FACP is Professor of Clinical Medicine at the University of California, San Francisco (UCSF) and an internationally recognized investigator whose work has advanced the integration of hepatology into primary care. Her research spans viral hepatitis, MASLD/MASH, cirrhosis, and hepatocellular carcinoma, with a particular emphasis on implementation science and population health approaches to liver disease.